Newsletter | February 24, 2026

02.24.26 -- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact

SPONSOR

Webinar: The Future of CGT Manufacturing Panel Discussion: Integrating Digital Solutions With Regulatory Readiness

Join MasterControl for an expert panel on the future of cell and gene therapy (CGT) manufacturing. Learn how leading organizations are tackling regulatory complexity, cGMP execution, and digital transformation as CGT scales to commercialization. Gain practical strategies to embed quality at the source, harmonize global compliance, and leverage digital tools to build resilient, future-ready CGT operations. Click here to learn more.

FOCUS ON MANUFACTURING

U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact

Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates. Turn complex trade policy into actionable procurement and outsourcing responses to shift with global mandates and supply chains.

Selecting CGT Manufacturing Processes For Automation

Inform your automation decision by pinpointing these crucial considerations and processes for successful batch productions. Understand how to prioritize adaptation for factors like human error risk and labor cost.

5 Advantages Of Single-Use Bioreactors

Reduce the time and cross contamination risks involved in maintaining a traditional bioreactor with this single-use solution for biopharmaceutical manufacturing.

Efficiently Optimize Your Workflow With Single-Use Chromatography

Explore how low-volume purification can be done more efficiently in GMP settings with a live system demo and customer insights on optimizing workflows with single-use chromatography.

The Hidden Cost Of Off-The-Shelf Media In Cell Therapy

Generic, off-the-shelf media can harbor hidden costs and delays in cell and gene therapy development. A strategic media approach is a critical advantage that can accelerate your path to the clinic.

Advancing Extracellular Vesicle Purification

Discover a novel solution designed to improve the purification and yield of nanoscale vesicles. This technology addresses key challenges in developing promising medical treatments.

Quantifying AAV Capsids Via Extended ddPCR

Assess AAV genome integrity beyond ITR-2. This extended ddPCR method allows for precise quantification of empty and full capsids, ensuring better characterization of your genomic targets.

Sustainable Cryopreservation In Biopharma

With the shift away from F-Gases, natural gas-driven refrigeration platforms provide a step to more sustainable cryopreservation. However, this new method also introduces new hurdles. Survey the pros and cons.

Efficient Mixing For Powdered Media And Buffers

Explore how this mixing system efficiently handles various powdered media and buffers, ensuring precise solubilization and mixing in applications like cell culture and protein purification.

Impactful Cell-Based Assays For Immuno-Oncology

Cell-based immunotherapy uses specialized immune cells to identify and eliminate cancer. Explore how these assays are shaping the future of cancer treatment and improving patient outcomes.

Sterile Micro-Connection Technology For Small-Format Applications

Aseptic micro-connectors offer a simple method for joining tubing in small assemblies. Improve efficiency and mitigate risk while reducing the total cost of your sterile fluid transfers.

Key Considerations When Selecting A Laboratory Incubator

Choosing the right incubator requires more than reading specs. Learn how to evaluate performance metrics, contamination control, and real-world functionality to make confident equipment decisions.

MANUFACTURING SOLUTIONS

Isolator For Fill/Finish Applications - AST

Customized Skid For Large LNP Production Scale - KNAUER

Automated Production Line For Vial Filling And Crimping - 3P innovation

Optimizing Performance For De-Risked Lentiviral Vector Production - MilliporeSigma

A Single Resource For Total Cleanroom Confidence - AES Cleanroom Technology

Connect With Cell & Gene: